Delivery Order SPE2DB25D3018-SPE2DB25FUXLY

Award Date 5/9/25
Potential Completion Date 5/12/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,261.06 firm fixed-price delivery order is for the supply of 100 tablets of 54 mg Methylphenidate ER, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,603.12 Firm Fixed Price delivery order contract is for the supply of Methylphenidate ER 18 mg tablets, a medication used to treat ADHD. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,168.40 Firm Fixed Price Delivery Order contract is for the supply of Methylphenidate ER 27 mg tablets, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract has an ultimate completion date of November 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,681.22 firm-fixed-price delivery order is for the supply of 4,566,504,596 tablets of 27mg extended-release methylphenidate, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,689.68 firm-fixed-price delivery order is for the supply of 100 units of Methylphenidate ER 27 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,500.45 firm-fixed-price delivery order is for the supply of 4,566,353,622 tablets of Methylphenidate ER 18 mg, a prescription medication used in the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The contract has a period of performance through November 7, 2024 and was awarded on November 6,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,877.16 delivery order is for the supply of Methylphenidate ER 36 mg tablets, a generic prescription medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,502.98 firm-fixed-price delivery order is for the supply of Methylphenidate ER 54 mg tablets, a prescription medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,282.16 firm fixed-price delivery order is for the supply of 4564882038 - Methylphenidate ER 36 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award has an ultimate completion date of June 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,414.83, is for the delivery of 18 mg extended-release methylphenidate tablets, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a period of performance through October 24, 2024 and is structured as a firm fixed-price...
  • SPE2DB25D3018
    Indefinite Delivery Contract
  • SPE2DB25D3018-SPE2DB25FUXLY
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,233.15 firm fixed-price delivery order is for the supply of 100 units of Methylphenidate ER 18 mg tablets, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract does not have a set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/8/25, 9:49 AM